NIKKEI 225
38,618.68 -328.25 (-0.84%) HANG SENG
19,277.38 +56.76 (+0.30%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,417.50 -8.40 (-0.35%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,959.40 -843.21 (-1.51%)
BMY May 2025 47.000 call
| Previous close | 2.5300 |
| Open | 2.7000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 47.00 |
| Expiry date | 2025-05-16 |
| Day's range | 2.5300 - 2.7000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Associated Press Finance
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
A Hawaii court has ordered the manufacturers and distributors of the blood thinner Plavix to pay the state a combined $916 million after finding the companies failed to disclose the efficacy and safety of the medication, the state attorney general said Tuesday. The judgement was issued against Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi. Bristol Myers Squibb and Sanofi said in a joint statement they disagreed with the penalty and plan to appeal.
Business WireBristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
PRINCETON, N.J., May 21, 2024--Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
Business WireBristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 21, 2024--Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivo and hyaluronidase)
